| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.476 | 33.260 | 24.765 | 26.495 | 24.297 | 26.248 |
| Total Income - EUR | - | - | - | - | 6.332 | 58.875 | 26.403 | 29.692 | 25.912 | 26.267 |
| Total Expenses - EUR | - | - | - | - | 6.700 | 38.148 | 31.788 | 38.524 | 24.539 | 26.538 |
| Gross Profit/Loss - EUR | - | - | - | - | -368 | 20.726 | -5.385 | -8.832 | 1.372 | -270 |
| Net Profit/Loss - EUR | - | - | - | - | -392 | 20.405 | -5.633 | -9.242 | 1.129 | -493 |
| Employees | - | - | - | - | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Bionur S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 10.107 | 7.320 | 18.279 | 11.345 | 8.088 | 5.285 |
| Current Assets | - | - | - | - | 31.596 | 16.131 | 9.761 | 1.711 | 3.072 | 2.548 |
| Inventories | - | - | - | - | 1.350 | 974 | 510 | 480 | 1.255 | 892 |
| Receivables | - | - | - | - | 10.958 | 289 | 8.550 | 0 | 0 | 424 |
| Cash | - | - | - | - | 19.288 | 14.868 | 701 | 1.231 | 1.817 | 1.232 |
| Shareholders Funds | - | - | - | - | -350 | 20.061 | 8.728 | -487 | 643 | 147 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 14.301 | 1.778 | 17.523 | 12.114 | 10.517 | 7.687 |
| Income in Advance | - | - | - | - | 27.753 | 1.612 | 1.789 | 1.430 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bionur S.r.l.